Authors
Kenneth Swenerton, John Jeffrey, Gavin Stuart, Michel Roy, Gary Krepart, John Carmichael, Pierre Drouin, Robert Stanimir, Gregory O'Connell, Grant MacLean
Publication date
1992/5
Journal
Journal of clinical oncology
Volume
10
Issue
5
Pages
718-726
Description
PURPOSE
Given the potential for improved tolerance, a trial was initiated to compare the toxicity and efficacy of a standard regimen of cisplatin-cyclophosphamide (75 mg/m2 and 600 mg/m2, respectively) with an experimental regimen of carboplatin-cyclophosphamide (300 mg/m2 and 600 mg/m2, respectively) in women with postoperative macroscopic residual ovarian cancer.
PATIENTS AND METHODS
Between 1985 and 1989, 447 (417 eligible) patients were randomized. Treatment arms were well balanced; most patients had stage III (82%), grade 3 (54%) tumors with bulky residual (greater than 2 cm in 59%), and good performance status (Eastern Cooperative Oncology Group [ECOG] 0 or 1, 77%). Response was assessed after six 4-week cycles.
RESULTS
The treatments were equally deliverable, with 76% of patients completing their allocated regimen. The reported reasons for failure to complete treatment …
Total citations
19921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202451241110161618108141414101381059884365751041422